Pharmaceutical care in chronic kidney disease: experience at Grenoble University Hospital from 2006 to 2010
Journal of Nephrology, 07/16/2012
Belaiche S et al. – The inclusion of a clinical pharmacist (CP) in the management of chronic kidney disease (CKD) patients is necessary for identification and prevention of DRPs. Besides the medical improvement of CKD patients, the CP participates in the development of prescription recommendations and therapeutic education programs for patients. Moreover, redefining roles and practices of members of a clinical team proved its efficiency in optimizing the medical care of CKD patients. Furthermore, patient entry into dialysis is postponed, which leads to a reduction in costs for health care insurance.